CA1301064C - Compositions immunomodulatrices et leur utilisation - Google Patents

Compositions immunomodulatrices et leur utilisation

Info

Publication number
CA1301064C
CA1301064C CA000541064A CA541064A CA1301064C CA 1301064 C CA1301064 C CA 1301064C CA 000541064 A CA000541064 A CA 000541064A CA 541064 A CA541064 A CA 541064A CA 1301064 C CA1301064 C CA 1301064C
Authority
CA
Canada
Prior art keywords
antigen
sequence
transplantation
cells
restricted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000541064A
Other languages
English (en)
Inventor
Malcolm L. Gefter
Jean-Gerard Guillet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Institute of Technology
Original Assignee
Massachusetts Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Institute of Technology filed Critical Massachusetts Institute of Technology
Application granted granted Critical
Publication of CA1301064C publication Critical patent/CA1301064C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CA000541064A 1986-06-30 1987-06-30 Compositions immunomodulatrices et leur utilisation Expired - Fee Related CA1301064C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88013486A 1986-06-30 1986-06-30
US880,134 1986-06-30

Publications (1)

Publication Number Publication Date
CA1301064C true CA1301064C (fr) 1992-05-19

Family

ID=25375576

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000541064A Expired - Fee Related CA1301064C (fr) 1986-06-30 1987-06-30 Compositions immunomodulatrices et leur utilisation

Country Status (2)

Country Link
CA (1) CA1301064C (fr)
IL (1) IL83039A (fr)

Also Published As

Publication number Publication date
IL83039A (en) 1994-04-12

Similar Documents

Publication Publication Date Title
US5019384A (en) Immunonodulating compositions and their use
EP0271577B1 (fr) Compositions immunomodulatrices et leur usage
Widmann et al. T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides
Zhu et al. Lipopeptide epitopes extended by an Nϵ‐palmitoyl‐lysine moiety increase uptake and maturation of dendritic cells through a Toll‐like receptor‐2 pathway and trigger a Th1‐dependent protective immunity
Shirai et al. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.
KR100290632B1 (ko) 면역성이약한항원공액체와이를포함하는합성펩티드담체와백신
AU766955B2 (en) Antigenic complex comprising immunostimulatory peptide, CD4, and chemokine receptor domain for HIV treatment and immune disorders
CA1340012C (fr) Determinant peptidique associe a l'immunite
EP0429816A1 (fr) Composition de vaccin à base d'un épitope non-immunosuppressif de cellules T
Romero et al. Immunization with synthetic peptides containing a defined malaria epitope induces a highly diverse cytotoxic T lymphocyte response. Evidence that two peptide residues are buried in the MHC molecule.
Jackson et al. The central role played by peptides in the immune response and the design of peptide-based vaccines against infectious diseases and cancer
TW202039587A (zh) 供合成胜肽免疫原作為免疫刺激劑的人工混雜t輔助細胞抗原決定位
CN102892431A (zh) 用于增强疫苗免疫原性的肽、偶联物及方法
SA519410007B1 (ar) مركبات ببتيد وطرق لمعالجة السكر
JPH10501682A (ja) 細胞毒性ｔ細胞エピトープ
US20050049197A1 (en) Induction of immune response against desired determinants
CN113574073A (zh) 针对降钙素基因相关肽(cgrp)的肽免疫原及其用于预防和治疗偏头痛的制剂
EP0531401A1 (fr) Renforcement de l'association de peptides exogenes avec des molecules mhc de la classe i sur des cellules de systems immuns.
TWI754817B (zh) 以人工混雜ｔ輔助細胞抗原決定位以有限度的ｔ細胞發炎反應促進目標抗體的生產
Dakappagari et al. Intracellular delivery of a novel multiepitope peptide vaccine by an amphipathic peptide carrier enhances cytotoxic T‐cell responses in HLA‐A* 201 mice
de Cerio et al. Th1 but not Th0 cell help is efficient to induce cytotoxic T lymphocytes by immunization with short synthetic peptides
EP0427768A1 (fr) Vaccin peptidique contre les toxines de la coqueluche
CA1301064C (fr) Compositions immunomodulatrices et leur utilisation
Gras-Masse Single-chain lipopeptide vaccines for the induction of virus-specific cytotoxic T cell responses in randomly selected populations
WO2010060208A1 (fr) Adjuvants peptidiques

Legal Events

Date Code Title Description
MKLA Lapsed